Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Multimedia
Events
About Us
MDMA approval
Lykos Therapeutics Slashes Workforce, Reshuffles Leadership After FDA Rejection
August
22
,
2024
Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead
June
7
,
2024
Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment
May
9
,
2024
Optimi Health Obtains Permit to Increase MDMA Production
January
19
,
2024